A new study has been published showcasing a new DNA-based nanobot that could open the door to producing life-saving drugs in the human body.

On August 6, 2020, President Donald J. Trump signed an executive order mandating the federal government to buy and give preference to certain "essential" drugs and medical supplies developed and made in the U.S. over those from overseas. The move is expected to plug gaps in the pharmaceutical supply chain that have been exposed by the coronavirus pandemic.

Rosemary Gibson talks about the risks of the U.S. depending on China to supply the essential ingredients for many of our most widely used medicines.